Literature DB >> 8990444

Ovarian and uterine disease in women with colorectal cancer.

N Abu-Rustum1, R R Barakat, J P Curtin.   

Abstract

OBJECTIVE: To identify the nature of adnexal and uterine disease in women with a history of colorectal adenocarcinoma who develop new pelvic masses or uterine cancers during follow-up.
METHODS: We conducted a retrospective chart review of the Memorial Hospital Gynecology Service database and identified 50 women, each with a history of colorectal carcinoma who underwent a hysterectomy or adnexectomy between January 1, 1977, and February 29, 1996. Subject characteristics, indications for re-operation, and findings at surgery were recorded.
RESULTS: The mean age at re-operation was 66 years (range, 37-76), with a median interval from initial diagnosis to re-operation of 25 months (range, 3-444). Indications for re-operation were: 1) new pelvic mass in 35 women, and 2) cancer on endometrial or cervical biopsy in 15. Twenty-six of the 35 (74%) women who presented with a pelvic mass had a malignancy in the ovary, with metastatic colon cancer noted in 20 of 26 (77%) women, and epithelial ovarian cancer in six of 26 (23%). The mean ovarian tumor size for metastatic colorectal carcinoma, ovarian cancer, and benign tumors was 15, 8, and 6 cm, respectively. Fifteen women underwent hysterectomy for a newly diagnosed cancer in the uterus, with the majority, 11 (73%), having endometrial adenocarcinoma, followed by metastatic colon cancer to the endometrium or cervix in three (20%) women, and primary cervical carcinoma in one.
CONCLUSION: Women with a history of colorectal cancer who underwent adnexectomy for a new pelvic mass had metastatic colon cancer to the ovary in 57%, benign ovarian neoplasm in 26%, and primary ovarian cancer in 17% of cases. Women who underwent hysterectomy for a newly diagnosed carcinoma in the uterus had primary endometrial adenocarcinoma in 73% and metastatic colon cancer in 20% of cases.

Entities:  

Mesh:

Year:  1997        PMID: 8990444     DOI: 10.1016/s0029-7844(96)00369-9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Uterine cervix metastasis from primary colorectal carcinoma: a report of two cases with review of literature.

Authors:  Rakesh Kapoor; Divya Khosla; Rajesh Gupta; Radhika Srinivasan; Amit Bahl; Ritesh Kumar; Suresh C Sharma
Journal:  J Gastrointest Cancer       Date:  2013-06

2.  Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis.

Authors:  Tomoki Yamano; Eiichi Morii; Isao Arai; Toshiaki Takada; Ken Kubota; Masahiko Sato; Takaaki Inoue; Yoshihiro Okada; Takahiko Hara; Katsuyuki Aozasa
Journal:  Int J Clin Oncol       Date:  2010-06-01       Impact factor: 3.402

3.  The role of chemotherapy and prophylactic bilateral oophorectomy in a case of colorectal adenocarcinoma with ovarian metastases.

Authors:  E K Shin; B T Takizawa; L Masters; S Shahabi
Journal:  Yale J Biol Med       Date:  2001 Mar-Apr

4.  Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan.

Authors:  Cherry Yin-Yi Chang; Kent Yu-Hsien Lin; Chien-Chu Huang; Wu-Chou Lin
Journal:  BMC Womens Health       Date:  2021-07-28       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.